What does Cue Biopharma, Inc. do?

Jun 22 2025 06:53 PM IST
share
Share Via
Cue Biopharma, Inc. is a development-stage immunotherapy company focused on creating biologics to target T cell subsets for cancer and autoimmune disease treatments. As of March 2025, it has a market cap of $43.71 million, with no net sales and a net loss of $12 million.
Overview:
Cue Biopharma, Inc. is a development-stage immunotherapy company focused on developing biologics to selectively modulate disease-relevant T cell subsets for the treatment of cancer and autoimmune diseases, operating in the Pharmaceuticals & Biotechnology industry with a micro-cap market classification. Financial Snapshot: Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -12 Million (Quarterly Results - Mar 2025) Market-cap: USD 43.71 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.94 Return on Equity: -616.78% Price to Book: 6.64 Contact Details: Address: 21 Erie St, CAMBRIDGE MA: 02139-4260 Tel: ['1 617 9492680', '1 617 9492602'] Fax: 1 302 6555049 Website: https://www.cuebiopharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Cue Biopharma, Inc. technically bullish or bearish?
Sep 20 2025 07:57 PM IST
share
Share Via
Is Cue Biopharma, Inc. overvalued or undervalued?
Sep 20 2025 06:31 PM IST
share
Share Via
Is Cue Biopharma, Inc. overvalued or undervalued?
Jun 25 2025 09:10 AM IST
share
Share Via
Is Cue Biopharma, Inc. technically bullish or bearish?
Jun 25 2025 08:56 AM IST
share
Share Via
Who are in the management team of Cue Biopharma, Inc.?
Jun 22 2025 10:38 PM IST
share
Share Via
How big is Cue Biopharma, Inc.?
Jun 22 2025 06:08 PM IST
share
Share Via